openPR Logo
Press release

Photobiostimulation Devices Market to Benefit from Rapid Technological Advancements During the Forecast 2020-2024 | Thor Photomedicine, Bioflex Laser Therapy, Ingeneus, iRestore Laser, Omega

05-01-2020 07:52 AM CET | Health & Medicine

Press release from: Business Industry Reports

Photobiostimulation Devices

Photobiostimulation Devices

Global Photobiostimulation Devices Market 2020-2024 examines the market in detail along with focusing on significant market dynamics for the key players in the market. This research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Global Photobiostimulation Devices Market overview:

BIR Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/173442 .

Photobiostimulating devices are used for reducing pain, inflammation and edema, promoting the healing of wounds, deeper tissue, and nerves, and preventing tissue damage. Modern photobiostimulation devices use LEDs to produce light of the required wavelength to achieve specific results. The Global Photobiostimulation Devices Market is segmented on the basis of Product Type, Application, End Use Industry and Region.

On the Basis of Product Type segment, the Photobiostimulation Devices Market is sub segmented into Infrared Light and Red Light. Based on End Use Industry segment, the Photobiostimulation Devices Market is sub segmented into Pain Management, Wound Care, Cosmetic Applications and Other Applications.

Some of the Photobiostimulation Devices Market manufacturers involved in the market are THOR Photomedicine Ltd, Bioflex Laser Therapy, Ingeneus Pty. Ltd, iRestore Laser, HairMax, LumiWave, Biolight Technologies, Omega Laser Systems, TheraDome Inc, Vielight Inc, iGrow Laser, Pulse Laser Relief in World, effective mergers are some of the strategies adopted by the Photobiostimulation Devices Market manufacturers. New product launches and continuous technological innovations are the Photobiostimulation Devices Market strategies adopted by the major players.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Photobiostimulation Devices Market Report 2020" @ https://www.businessindustryreports.com/buy-now/173442/single .

Photobiostimulation Devices is a form of light therapy that utilises light sources including lasers and light emitting diodes (LEDs) irradiating wavelengths in the visible and near infrared spectrum. Photobiostimulation Devices involves the light source being applied to the skin, allowing the light energy (photons) to penetrate tissue where Photobiostimulation Devices interacts with chromophores located in cells resulting in photophysical and photochemical changes that lead to alterations at the molecular, cellular and tissular levels of the body. Photobiostimulation Devices is a non-thermal, non-ionising process. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study.

There are several manufacturers of Photobiostimulation Devices in Europe and North America. In North America, the demand for Photobiostimulation Devices is primarily driven by the Healthcare sector. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India. These countries have been witnessing rapid increase in its population along with expansion of their overall economies, which has led to increase in disposable income.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/173442 .

Top Industry News:

LumiThera to Expand Research into Diabetic Retinopathy for Valeda Light Delivery System on 14 Feb, 2020 -- LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has initiated further studies with the University of Wisconsin-Milwaukee to establish the use of their Photobiomodulation platform in Diabetic Retinopathy (DR).

"Recent research in our labs in both preclinical and clinical areas have indicated potential in treating diabetic edema with PBM," stated Janis Eells, Ph.D., Professor, University of Wisconsin-Milwaukee. "Our work shows that early PBM benefits in reducing the detrimental effects of high glucose on retinal cells and early human data is now starting to show benefits in the clinical setting."

DR is the leading cause of blindness in the world. The International Diabetes Foundation 2019 Fact Sheet estimated that globally 463 million people have diabetes now, and future estimates suggest that this number will increase to 578 million by the year 2030.

"We have been working with Dr. Eells and the University of Wisconsin-Milwaukee on our dry AMD research and the work in DR and Diabetic Macular Edema (DME) is a logical extension of our PBM platform," stated Clark E. Tedford, Ph.D., President and CEO of LumiThera, Inc. "The results from Dr. Eell's lab point to the multiple cellular benefits of treating the disease early and PBM would be an alternative approach for treatment of early disease."

LumiThera was granted a CE mark to commercialize the Valeda System in European Union for the treatment of ocular diseases including dry AMD. The company previously announced that the National Institutes of Health and division of the National Eye Institute have provided a $2.5M grant to support the LIGHTSITE II multi-center clinical trial to lead to U.S. approval for dry AMD. The Company is enrolling two multi-center trials, one in European Union and one in the US for dry AMD. The entry into DME provides a second major ocular disease platform for the Valeda system.

"We are excited to be involved in the development of Valeda for both non-neovascular (dry) AMD and DME. We are currently enrolling patients in the LIGHTSITE III study and believe that PBM could be an even bigger platform for DME," remarked Quan Dong Nguyen, M.D., M.Sc. and Diana V. Do, M.D., Professors of Ophthalmology at the Byers Eye Institute, Stanford University. "DME is the leading cause of functional vision loss among working adults worldwide. Treatments with intravitreal injections of pharmacologic agents are effective but can be costly and invasive. PBM could provide a significant improvement to the current practices with its non-invasive approach."

Table of Contents:

1 Photobiostimulation Devices Product Definition
2 Global Photobiostimulation Devices Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Photobiostimulation Devices Shipments
2.2 Global Manufacturer Photobiostimulation Devices Business Revenue
2.3 Global Photobiostimulation Devices Market Overview
3 Manufacturer Photobiostimulation Devices Business Introduction
3.1 THOR Photomedicine Ltd Photobiostimulation Devices Business Introduction
3.1.1 THOR Photomedicine Ltd Photobiostimulation Devices Shipments, Price, Revenue and Gross profit 2020-2024
3.1.2 THOR Photomedicine Ltd Photobiostimulation Devices Business Distribution by Region
3.1.3 THOR Photomedicine Ltd Interview Record
3.1.4 THOR Photomedicine Ltd Photobiostimulation Devices Business Profile
3.1.5 THOR Photomedicine Ltd Photobiostimulation Devices Product Specification
3.2 Bioflex Laser Therapy Photobiostimulation Devices Business Introduction
3.2.1 Bioflex Laser Therapy Photobiostimulation Devices Shipments, Price, Revenue and Gross profit 2020-2024
3.2.2 Bioflex Laser Therapy Photobiostimulation Devices Business Distribution by Region
3.2.3 Interview Record
3.2.4 Bioflex Laser Therapy Photobiostimulation Devices Business Overview
3.2.5 Bioflex Laser Therapy Photobiostimulation Devices Product Specification
3.3 Ingeneus Pty. Ltd. Photobiostimulation Devices Business Introduction
3.3.1 Ingeneus Pty. Ltd. Photobiostimulation Devices Shipments, Price, Revenue and Gross profit 2020-2024
3.3.2 Ingeneus Pty. Ltd. Photobiostimulation Devices Business Distribution by Region
3.3.3 Interview Record
3.3.4 Ingeneus Pty. Ltd. Photobiostimulation Devices Business Overview
3.3.5 Ingeneus Pty. Ltd. Photobiostimulation Devices Product Specification
3.4 iRestore Laser Photobiostimulation Devices Business Introduction
3.5 HairMax Photobiostimulation Devices Business Introduction
3.6 LumiWave Photobiostimulation Devices Business Introduction
................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Photobiostimulation Devices Market to Benefit from Rapid Technological Advancements During the Forecast 2020-2024 | Thor Photomedicine, Bioflex Laser Therapy, Ingeneus, iRestore Laser, Omega here

News-ID: 2031715 • Views:

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo International, Nuvo Pharma, Ferndale Pharma, Galen, Jazz Pharma, Paladin Labs, St Renatus, MSK Pharma
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Lockheed Martin, BAE System, Boeing, General Dynamic, Raytheon) | Forecast to 2025
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growth by Top Key Company’s - J&J, Medtronic, B Braun, Boston Medical, Integra, Stryker, Zimmer, CONMED
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key Players - Apple, Fitbit, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Photobiostimulation

Photobiostimulation Devices Market to Witness an Outstanding Growth During  For …
The Photobiostimulation Devices Market is all set to create greater strides for the Photobiostimulation Devices Market in the upcoming period. Big data analytics is flowing through the veins of the healthcare vertical these days. This practice helps in providing better insights to healthcare practitioners. The healthcare vertical has started depending on analytics' expertise for deciphering data collected through various sources and monitoring processes' efficiency. Photobiostimulation therapy is also known as low-intensity
Medical Photobiostimulation System market forecast to see 6.3 % CAGR to 2028
The proposed Medical Photobiostimulation System market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. The medical photobiostimulation system market is projected to reach
Photobiostimulation Devices Market to Expand at 6% CAGR During 2019 - 2027
Transparency Market Research (TMR) has published a new report on the photobiostimulation devices market for the forecast period of 2019 to 2027. According to the report, the global photobiostimulation devices market was valued at US$ 180 Mn in 2018, and is projected to expand at a CAGR of more than 6% from 2019 to 2027, to reach a market value exceeding US$ 300 Mn by 2027 end. The global photobiostimulation devices
Medical Photobiostimulation System Market to Emerge with $314.88 million by 2028 …
The Medical Photobiostimulation System market research report by the insight partners includes market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2021 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the Medical Photobiostimulation System market
The Photobiostimulation Devices Market To Scale Vertically Upwards Between 2018- …
Market Overview Photobiostimulation therapy is also known as low-level light therapy (LLLT). Photobiostimulating devices are used for reducing pain, inflammation, and edema, promoting the healing of wounds, deeper tissue, and nerves, and preventing tissue damage. Modern photobiostimulation devices use LEDs to produce light of the required wavelength to achieve specific results. The predominant principle on which photobiostimulation devices work is that, light works on a protein in the mitochondria of the
Photobiostimulation Devices Market Revenue, Industry Growing Demand, Size, Share …
Transparency Market Research (TMR) has published a new report on the photobiostimulation devices market for the forecast period of 2019 to 2027. Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=66995 • According to the report, the global photobiostimulation devices market was valued at US$ 180 Mn in 2018, and is projected to expand at a CAGR of more than 6% from 2019 to 2027, to reach a market value exceeding US$ 300 Mn by 2027 end.